The Discounted Cash Flow (DCF) valuation of Transmedics Group Inc (TMDX) is (22.63) USD. With the latest stock price at 114.56 USD, the upside of Transmedics Group Inc based on DCF is -119.7%.
Based on the latest price of 114.56 USD and our DCF valuation, Transmedics Group Inc (TMDX) is a sell. selling TMDX stocks now will result in a potential gain of 119.7%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 9.7% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (41.04) - (16.99) | (22.63) |
| Upside | -135.8% - -114.8% | -119.7% |